TG Therapeutics | TGTX - Market Capitalization


TG Therapeutics reported $8.26B in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 444.6B 59.91B Jun/2026
Alaunos Therapeutics USD 7M 2M Mar/2026
Amgen USD 195.44B 5.55B Jun/2026
Ardelyx USD 1.48B 63M Mar/2026
Arrowhead Research USD 11.5B 2.72B Jun/2026
Bayer EUR 47.56B 8.87B Jun/2026
Biogen USD 31.9B 5B Jun/2026
Corcept Therapeutics USD 9.33B 5.02B Jun/2026
Curis USD 22M 9M Mar/2026
Gilead Sciences USD 156.86B 16.13B Jun/2026
J&J USD 611.36B 32.21B Jun/2026
Karyopharm Therapeutics USD 126M 9M Mar/2026
Novartis USD 240.59B 67.17B Jun/2026
Novavax USD 1.09B 316M Dec/2025
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
TG Therapeutics USD 8.41B 3.1B Jun/2026
Verastem USD 466M 130M Mar/2026
Vertex Pharmaceuticals USD 126.07B 12.49B Jun/2026